SMAD3 and systemic sclerosis: TGF-β induced expression of CHAC1, a SCENIC-predicted downstream target of SMAD3 was inhibited by SIS3, a specific inhibitor of Smad3 phosphorylation57 in dermal fibroblasts from both control and SSc subjects (Supplementary Fig. 22).